WASATCH ADVISORS LP - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 132 filers reported holding FLEXION THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
WASATCH ADVISORS LP ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$21,924,000
-36.4%
3,594,167
-14.1%
0.09%
-36.4%
Q2 2021$34,446,000
-8.6%
4,185,445
-0.6%
0.14%
-17.2%
Q1 2021$37,693,000
-20.5%
4,211,446
+2.5%
0.17%
-27.5%
Q4 2020$47,423,000
+26.2%
4,109,494
+13.9%
0.23%
-2.5%
Q3 2020$37,567,000
-20.8%
3,608,721
-0.0%
0.24%
-30.3%
Q2 2020$47,455,000
+160.4%
3,608,778
+55.8%
0.34%
+80.5%
Q1 2020$18,224,000
-59.4%
2,315,642
+6.8%
0.19%
-48.4%
Q4 2019$44,895,000
+65.9%
2,168,857
+9.9%
0.37%
+42.6%
Q3 2019$27,054,000
+102.3%
1,974,059
+81.6%
0.26%
+98.5%
Q2 2019$13,372,000
+5.4%
1,087,130
+7.0%
0.13%
-5.8%
Q1 2019$12,681,000
+18.9%
1,016,137
+7.8%
0.14%
-2.8%
Q4 2018$10,668,000
-31.2%
942,386
+13.8%
0.14%
-19.8%
Q3 2018$15,496,000
-7.5%
828,224
+27.8%
0.18%
-12.4%
Q2 2018$16,749,000
+18.1%
647,931
+2.4%
0.20%
+10.4%
Q1 2018$14,178,000
-15.6%
632,671
-5.7%
0.18%
-17.9%
Q4 2017$16,792,000
-31.1%
670,602
-33.4%
0.22%
-32.6%
Q3 2017$24,359,000
+18.3%
1,007,404
-1.1%
0.33%
+15.3%
Q2 2017$20,588,000
+19.3%
1,018,219
+58.7%
0.29%
+13.0%
Q1 2017$17,262,000
-1.2%
641,474
-30.2%
0.25%
-3.8%
Q4 2016$17,480,000
+8.6%
919,035
+11.6%
0.26%
+10.0%
Q3 2016$16,091,000
+28.7%
823,491
-1.5%
0.24%
+25.7%
Q2 2016$12,507,000
+72.0%
835,781
+3.4%
0.19%
+72.1%
Q1 2016$7,273,000
-4.7%
808,066
+104.1%
0.11%
+5.7%
Q4 2015$7,628,000
+2.1%
395,868
-21.3%
0.10%
+5.0%
Q3 2015$7,474,000
+9.0%
502,992
+60.6%
0.10%
+33.3%
Q2 2015$6,854,000313,1050.08%
Other shareholders

There were no reported owners of FLEXION THERAPEUTICS INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of FLEXION THERAPEUTICS INC shareholders